{"symbol": "SLS", "companyName": "SELLAS Life Sciences Group Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "https://www.sellaslifesciences.com", "description": "SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S and NeuVax.", "CEO": "Angelos Stergiou", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}